| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 996 | 0 |
| Total Expenses - EUR | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.390 | 0 |
| Gross Profit/Loss - EUR | -20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.394 | 0 |
| Net Profit/Loss - EUR | -20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.554 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vargyas Bioteka S.r.l.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 11.509 | 11.314 | 0 | 10.969 | 10.685 | 10.448 | 10.480 | 10.449 | 0 | 0 |
| Inventories | 11.509 | 11.314 | 0 | 10.891 | 10.685 | 10.448 | 10.480 | 10.449 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 77 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -11.116 | -10.928 | 0 | -10.520 | -10.320 | -10.092 | -10.123 | -10.092 | -19.589 | -19.328 |
| Social Capital | 45 | 44 | 0 | 42 | 41 | 40 | 41 | 40 | 40 | 40 |
| Debts | 22.625 | 22.242 | 0 | 21.488 | 21.005 | 20.540 | 20.603 | 20.541 | 19.589 | 19.328 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Vargyas Bioteka S.r.l.